No Prescription |
 |
 | ||
|
Orlistat Generic Orlistat |
|
| ||
No Prescription » Prescription Drugs 17 » Orlistat Generic Orlistat Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Part of a diet plan to help you lose weight - Orlistat is a prescription medication that can help considerably overweight people lose weight and keep it off. We know that managing your weight can be frustrating and sometimes you need a little extra support. Support you can't find in a pill alone. To succeed you may have to change the way you feel about food and about your body.The prescription medication from Roche is called Orlistat. Orlistat is a pill that is taken with meals and has been shown to reduce weight in considerably overweight people.It is FDA approved for people who are at least 30 pounds overweight depending on height. Orlistat does not act directly on the central nervous system. Orlistat should be taken with a reduced calorie diet containing no more than 30% of calories from fat.Chemical Name: ORLISTAT (OR-li-stat) Orlistat is used with a low-calorie diet to help you lose weight and to maintain your weight after weight loss. Orlistat is used in patients with a certain weight who may also have high blood pressure diabetes high cholesterol or heart disease. Buy Orlistat Generic Orlistat and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Orlistat Generic Orlistat: Product Type: Prescription Drugs 17 Orlistat ( Generic Orlistat ) Orlistat (Generic Orlistat) Generic Orlistat 120mg Generic Orlistat Orlistat
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
